Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Medicare Advantage plans will offer new supplemental benefits for many enrollees in 2019, according to a recent analysis by Washington, D.C.-based consulting firm Avalere Health.
Facebook posts can be very telling, as one recent study revealed an algorithm could predict depression in patients based on their posts with a fair amount of accuracy.
A research team has been awarded a grant to develop a mobile application aimed at raising awareness about diabetes for people in India who are most at risk for developing the disease.
The Sequoia Project is planning to host an interoperability forum dedicated to addressing the most pressing challenges regarding information sharing in healthcare.
Patients tend to like video telehealth visits with their doctors, according to researchers from Kaiser Permanente, who wrote a letter to the New England Journal of Medicine about recent survey results.
Surgeons will be using an Apple Watch app to help monitor the basic health data of patients who’ve undergone hip or knee replacement surgery, according to a report by Reuters.
The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns.
If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?
